GlassScriptPhysician profile
Kelly Suzanne Schmidt
NPI 1811199235
$5,109.27
in general payments reported to CMS, 2019-2025
16 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $142 · 2021: $388 · 2022: $1,915 · 2023: $677 · 2024: $18.10 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480 · Travel and Lodging: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.82 |
| Travel and Lodging | $617.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,047.87 | 2021-2023 | Stealthstation S8 Platform |
| Monteris Medical Corporation | $950.10 | 2025 | Neuroblate |
| Livanova USA, INC. | $519.41 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Kls-Martin L.P. | $514.43 | 2020-2025 | |
| Stryker Corporation | $441.73 | 2019-2022 | |
| Gt Medical Technologies, INC | $275.11 | 2023-2025 | Gammatile, Gammatile |
| Depuy Synthes Sales INC. | $82.57 | 2021 | |
| Cerapedics INC. | $79.94 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Glaxosmithkline, LLC. | $44.51 | 2020-2021 | |
| Ptc Therapeutics, INC. | $43.96 | 2019-2020 | |
| Eton Pharmaceuticals, INC. | $20.39 | 2025 | Khindivi, Increlex, Alkindi |
| Tandem Diabetes Care, INC. | $19.93 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.10 | 2024 | Dysport |
| Itf Therapeutics LLC | $17.45 | 2025 | |
| Ucb, INC. | $17.11 | 2025 | Fintepla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $16.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.